HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carsten Bokemeyer Selected Research

mycalamide A

6/2012Mycalamide A shows cytotoxic properties and prevents EGF-induced neoplastic transformation through inhibition of nuclear factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carsten Bokemeyer Research Topics

Disease

205Neoplasms (Cancer)
12/2022 - 03/2002
56Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
12/2022 - 04/2002
32Prostatic Neoplasms (Prostate Cancer)
03/2022 - 03/2007
28Neoplasm Metastasis (Metastasis)
12/2022 - 04/2002
27Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2003
25Testicular Neoplasms (Testicular Cancer)
12/2022 - 04/2002
21Seminoma
12/2022 - 04/2002
16Multiple Myeloma
01/2022 - 02/2007
15Breast Neoplasms (Breast Cancer)
06/2020 - 01/2003
14Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2022 - 12/2006
14Adenocarcinoma
02/2022 - 05/2007
14Disease Progression
10/2021 - 03/2002
13Stomach Neoplasms (Stomach Cancer)
10/2015 - 05/2007
12Carcinoma (Carcinomatosis)
01/2021 - 05/2002
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 04/2003
10BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2021 - 01/2003
9Anemia
04/2013 - 01/2005
8Leukemia
06/2022 - 05/2005
7Ascites
08/2014 - 12/2009
6Infections
12/2022 - 07/2014
6Neutropenia
06/2019 - 07/2007
5Febrile Neutropenia
01/2022 - 07/2007
5Hemorrhage
09/2021 - 01/2015
5Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 01/2008
5Lung Neoplasms (Lung Cancer)
01/2021 - 01/2011
5Squamous Cell Carcinoma of Head and Neck
12/2020 - 09/2006
5Chemotherapy-Induced Febrile Neutropenia
06/2019 - 01/2016
4Fever (Fevers)
01/2022 - 08/2014
4Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 01/2018
4Disseminated Intravascular Coagulation
07/2021 - 06/2008
4Lymphoma (Lymphomas)
01/2021 - 01/2011
4Thrombosis (Thrombus)
01/2020 - 09/2015
4Blast Crisis (Blast Phase)
12/2019 - 05/2003
4Nausea
01/2017 - 12/2006
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2016 - 09/2006
4Necrosis
09/2015 - 12/2008

Drug/Important Bio-Agent (IBA)

46Cisplatin (Platino)FDA LinkGeneric
12/2022 - 03/2002
28Proteins (Proteins, Gene)FDA Link
07/2020 - 02/2003
23Biomarkers (Surrogate Marker)IBA
12/2020 - 09/2010
18AntigensIBA
01/2022 - 09/2006
18AntibodiesIBA
01/2022 - 03/2009
17PlatinumIBA
01/2019 - 04/2002
16Pharmaceutical PreparationsIBA
12/2020 - 02/2003
15Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 06/2004
14Cetuximab (Erbitux)FDA Link
01/2021 - 09/2008
14ErbB Receptors (EGF Receptor)IBA
01/2019 - 03/2006
12Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020 - 01/2003
11Phosphotransferases (Kinase)IBA
03/2022 - 01/2006
10Thromboplastin (Tissue Factor)IBA
08/2021 - 03/2007
10Biological ProductsIBA
07/2021 - 04/2002
8Leucovorin (Folinic Acid)FDA Link
01/2020 - 06/2004
8Tyrosine Kinase InhibitorsIBA
12/2019 - 05/2005
8Tumor Biomarkers (Tumor Markers)IBA
11/2019 - 05/2002
8GemcitabineFDA Link
01/2019 - 04/2003
8ProteomeIBA
06/2017 - 09/2008
8Imatinib Mesylate (Gleevec)FDA Link
04/2011 - 01/2003
7Carboplatin (JM8)FDA LinkGeneric
01/2021 - 04/2003
7Hemoglobins (Hemoglobin)IBA
01/2018 - 01/2005
7catumaxomabIBA
10/2015 - 08/2010
6DNA (Deoxyribonucleic Acid)IBA
03/2022 - 10/2012
6Etoposide (VP 16)FDA LinkGeneric
10/2021 - 04/2003
6Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 03/2006
6Trastuzumab (Herceptin)FDA Link
06/2020 - 06/2009
6Biosimilar PharmaceuticalsIBA
06/2019 - 01/2016
6Filgrastim (Neupogen)FDA Link
06/2019 - 01/2016
6AutoantibodiesIBA
04/2015 - 01/2010
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2015 - 03/2006
6Irinotecan (Camptosar)FDA LinkGeneric
07/2009 - 01/2003
5Bleomycin (Blenoxane)FDA LinkGeneric
12/2022 - 04/2008
5Cytarabine (Cytosar-U)FDA LinkGeneric
11/2022 - 01/2013
5larotrectinibIBA
03/2022 - 01/2021
5Transcription Factors (Transcription Factor)IBA
12/2021 - 01/2013
5L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2021 - 01/2013
5Dacarbazine (DIC)FDA LinkGeneric
07/2021 - 06/2008
5AlkaloidsIBA
12/2020 - 04/2012
5Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
01/2020 - 04/2002
5Bevacizumab (Avastin)FDA Link
01/2019 - 12/2009
5Protein Isoforms (Isoforms)IBA
06/2017 - 01/2006
5Epithelial Cell Adhesion MoleculeIBA
07/2014 - 08/2010
5Prostate-Specific Antigen (Semenogelase)IBA
06/2013 - 03/2007
5HematinicsIBA
04/2013 - 02/2008
4N- succinimidyl- 5- iodo- 3- pyridinecarboxylic acidIBA
03/2021 - 01/2017
4EnzymesIBA
12/2020 - 01/2012
4Doxorubicin (Adriamycin)FDA LinkGeneric
05/2020 - 09/2006
4Messenger RNA (mRNA)IBA
01/2019 - 03/2002
4Panitumumab (Vectibix)FDA Link
01/2019 - 07/2009
4EpitopesIBA
01/2019 - 05/2015
4Thomsen-Friedenreich antigenIBA
01/2016 - 03/2007
4Peptide Initiation Factors (Initiation Factor)IBA
07/2015 - 02/2007

Therapy/Procedure

106Drug Therapy (Chemotherapy)
12/2022 - 04/2002
101Therapeutics
12/2022 - 01/2003
17Palliative Care (Palliative Therapy)
01/2022 - 01/2012
13Radiotherapy
01/2022 - 04/2002
12Immunotherapy
02/2022 - 09/2006
9Salvage Therapy
12/2022 - 11/2003
9Castration
02/2022 - 06/2013
9Stem Cell Transplantation
01/2022 - 02/2007
9Combination Drug Therapy (Combination Chemotherapy)
12/2018 - 03/2006
7Prostatectomy (Retropubic Prostatectomy)
01/2018 - 06/2009
4Aftercare (After-Treatment)
09/2021 - 10/2011